Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Sasadeusz

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of the International AIDS Society|November 14, 2014
Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysisMarisa Montes, Mark Nelson, Pierre Marie Girard, et al.
Open Forum Infectious Diseases|October 9, 2025
Incidence and Clinical Outcomes of Multiple Viral Infections After Allogeneic Hematopoietic Cell TransplantationKar Yee Yong, Shio Yen Tio, Beatrice Z Sim, et al.
Hepatology (Baltimore, Md.)|September 18, 2016
Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II studyMarianne Martinello, Edward Gane, Margaret Hellard, et al.
Plos One|April 18, 2013
Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individualsGail V Matthews, Rachel J Ali, Anchalee Avihingsanon, et al.
AIDS (London, England)|July 9, 2009
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individualsGail V Matthews, Eric Seaberg, Gregory J Dore, et al.
AIDS (London, England)|March 8, 2016
Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversityJennifer Audsley, Stephen J Bent, Margaret Littlejohn, et al.
AIDS (London, England)|May 6, 2008
The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patientsJoe Sasadeusz, Jennifer Audsley, Anne Mijch, et al.
Hepatology (Baltimore, Md.)|August 13, 2008
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in ThailandGail V Matthews, Anchalee Avihingsanon, Sharon R Lewin, et al.
Plos One|June 20, 2020
Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage studyEmma Foster, Michael J Malloy, Vilija G Jokubaitis, et al.
The Journal of Infectious Diseases|June 11, 2016
Toll-like Receptor Expression and Signaling in Peripheral Blood Mononuclear Cells Correlate With Clinical Outcomes in Acute Hepatitis C Virus InfectionSwee Lin G Chen Yi Mei, Jodie Burchell, Narelle Skinner, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of the International AIDS Society|November 14, 2014
Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysisMarisa Montes, Mark Nelson, Pierre Marie Girard, et al.
Open Forum Infectious Diseases|October 9, 2025
Incidence and Clinical Outcomes of Multiple Viral Infections After Allogeneic Hematopoietic Cell TransplantationKar Yee Yong, Shio Yen Tio, Beatrice Z Sim, et al.
Hepatology (Baltimore, Md.)|September 18, 2016
Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II studyMarianne Martinello, Edward Gane, Margaret Hellard, et al.
Plos One|April 18, 2013
Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individualsGail V Matthews, Rachel J Ali, Anchalee Avihingsanon, et al.
AIDS (London, England)|July 9, 2009
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individualsGail V Matthews, Eric Seaberg, Gregory J Dore, et al.
AIDS (London, England)|March 8, 2016
Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversityJennifer Audsley, Stephen J Bent, Margaret Littlejohn, et al.
AIDS (London, England)|May 6, 2008
The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patientsJoe Sasadeusz, Jennifer Audsley, Anne Mijch, et al.
Hepatology (Baltimore, Md.)|August 13, 2008
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in ThailandGail V Matthews, Anchalee Avihingsanon, Sharon R Lewin, et al.
Plos One|June 20, 2020
Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage studyEmma Foster, Michael J Malloy, Vilija G Jokubaitis, et al.
The Journal of Infectious Diseases|June 11, 2016
Toll-like Receptor Expression and Signaling in Peripheral Blood Mononuclear Cells Correlate With Clinical Outcomes in Acute Hepatitis C Virus InfectionSwee Lin G Chen Yi Mei, Jodie Burchell, Narelle Skinner, et al.
Pageof 7